Cargando…

High vaccination coverage slows down genetic diversity of SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Liu, Yuqi, Li, Peihan, Yang, Lang, Li, Peng, Song, Hongbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The British Infection Association. Published by Elsevier Ltd. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988574/ https://www.ncbi.nlm.nih.gov/pubmed/35398408 http://dx.doi.org/10.1016/j.jinf.2022.04.009

Ejemplares similares

Down‐regulation of SARS‐CoV‐2 neutralizing antibodies in vaccinated smokers
por: Zhang, Jiahui, et al.
Publicado: (2022)

Effect of a SARS-CoV-2 booster vaccine dose on the immune response of adults with Down syndrome
por: Yarci-Carrión, Ayla, et al.
Publicado: (2022)

Ratcheting down the virulence of SARS‐CoV‐2 in the COVID‐19 pandemic
por: Brufsky, Adam, et al.
Publicado: (2020)

COVID-19 subgroups may slow down biological age acceleration
por: Guo, Yu, et al.
Publicado: (2023)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Cancer screening coverage in Poland – from bad to better to the worst during the SARS-CoV-2 pandemic
por: Koczkodaj, Paweł, et al.
Publicado: (2021)

SARS-CoV-2 and the myths about vaccination()
por: Travezaño-Cabrera, Aaron, et al.
Publicado: (2021)

Immunophenotyping of SARS-CoV-2 and vaccine design
por: Cimolai, Nevio
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine: Correspondence
por: Sriwijitalai, Won, et al.
Publicado: (2023)

Acute interstitial nephritis following SARS-CoV-2 vaccination
por: Wu, Henry H L, et al.
Publicado: (2021)

Time of day influences immune response to an inactivated vaccine against SARS-CoV-2
por: Zhang, Hui, et al.
Publicado: (2021)

SARS CoV-2 genetic jump to a new SARS CoV-3 pandemic: Let’s be prepared
por: Kelleni, Mina T.
Publicado: (2023)

Commentary: SARS-CoV-2 vaccines and cancer patients
por: Corti, C., et al.
Publicado: (2021)

Impact of SARS-CoV-2 vaccines on the nervous system
por: Scorza, Fulvio Alexandre, et al.
Publicado: (2022)

Graves’ disease following SARS-CoV-2 vaccination
por: Sriphrapradang, Chutintorn, et al.
Publicado: (2021)

Vaccination of susceptible animals against SARS-CoV-2
por: Xiang, Bin, et al.
Publicado: (2022)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

SARS‐CoV‐2 vaccinations can trigger polyradiculitis
por: Finsterer, Josef, et al.
Publicado: (2022)

Subacute thyroiditis and different SARS-CoV-2 vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
por: García-Cruces-Méndez, Jesús Fernando, et al.
Publicado: (2022)

Rate and risk factors for breakthrough SARS-CoV-2 infection after vaccination
por: Butt, Adeel A., et al.
Publicado: (2021)

Guillain-Barré syndrome and SARS-CoV-2
por: Lampe, Anne, et al.
Publicado: (2020)

Will SARS-COV-2 infection accelerate the incidence of Alzheimer's disease in Down syndrome population?
por: Barišić, Anita, et al.
Publicado: (2022)

Back to the basics: Hand washing is public health 101 and it works to slow down the spread of viruses
por: Tabish, Hilary B., et al.
Publicado: (2020)

Measles Vaccination Coverage and Cases among Vaccinated Persons
por: Althaus, Christian L., et al.
Publicado: (2015)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

SARS CoV2 mRNA vaccines: Prolonged dosing intervals and anti-SARS-CoV-2 immunity status
por: Ghazvini, Kiarash, et al.
Publicado: (2022)

Non-epileptic myoclonus status can be due to both SARS-CoV-2 infection and SARS-CoV-2 vaccination
por: Finsterer, Josef
Publicado: (2023)

Weakened humoral immune responses of inactivated SARS‐CoV‐2 vaccines in patients with solid tumors
por: Chen, Zhiwei, et al.
Publicado: (2022)

Factor associated with SARS-CoV-2 vaccination serological efficacy in adolescents and adults with Down syndrome: Data from an international, collaborative initiative of the Trisomy 21 Research Society
por: Valentini, D., et al.
Publicado: (2023)

Vitamin D deficiency and inactivated SARS-CoV-2 vaccines
por: Wu, Chia-Chao, et al.
Publicado: (2021)

Deaths associated with newly launched SARS-CoV-2 vaccination
por: Mungmunpuntipamtip, Rujittika, et al.
Publicado: (2021)

Lack of vaccination in ventilated patients for SARS-CoV-2 in France
por: Joannes-Boyau, Olivier, et al.
Publicado: (2022)

Glomerular endothelial injury following vaccination for SARS-CoV-2
por: Tanemoto, Masayuki, et al.
Publicado: (2021)

SARS-CoV-2 re-infection, vaccination and neutralizing antibodies
por: Bongiovanni, Marco, et al.
Publicado: (2022)

Screening for SARS-CoV-2 antibodies to save vaccine doses
por: Fenollar, Florence, et al.
Publicado: (2022)

Hashimoto encephalopathy after vaccination against SARS-CoV-2
por: Viscasillas Sancho, M., et al.
Publicado: (2022)

Post-SARS-CoV-2 vaccination thrombosis is frequent and ubiquitous
por: Finsterer, Josef
Publicado: (2022)

Sinopharm Vaccine, SARS-CoV-2 Breakthrough Infections and Hemoglobinopathies
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS-CoV-2 vaccination and thrombotic risk in myeloproliferative neoplasms
por: Borsani, Oscar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_61ug4u10i9kipge76prduvg1mi